ISPE Thailand has been delivered technical and operational solutions to support pharmaceutical industry in the manufacture of quality, safety and efficiency medicines for patients all along. This year ISPE Thailand Annual Meeting focuses on how pharmaceutical companies adhere to rigorous medical standards to ensure patient safety while implementing innovative strategies to reduce pollution and conserve natural resources. We, therefore, come up with theme “Quality & Sustainability”.
The modern pharmaceutical industry is undergoing a strategic transformation, actively balancing strict Good Manufacturing Practice (GMP) quality standards with aggressive sustainability goals. While traditionally defined by energy-intensive manufacturing and linear waste models, the sector now integrates green chemistry, eco-design principles, and digital Quality Management Systems (QMS) to reduce its environmental footprint without compromising patient safety.
Adopting a sustainable strategy is no longer just a "nice-to-have" for pharmaceutical companies; it is a fundamental requirement for long-term viability and stakeholder trust. By prioritizing sustainability, companies can move beyond mere regulatory compliance to building resilience and deep-seated credibility with the partners—governments, global institutions, and investors—who determine the industry's future success. Here is an overview of the tracks and sessions of the ISPE Thailand Annual General Meeting (AGM) 2026.

ISPE Thailand aims to
• Prepare professionals for the challenges and opportunities of an evolving industry landscape
• Foster global discussions centered on excellence, modernization and harmonization within the pharmaceutical industry
• Engage participants with international experts who share valuable insights
• Connect local and international professionals in the pharmaceutical & biopharmaceutical fields
In addition, the participants will benefit from a full program of sessions covering diverse topics by:
• Getting update from Thai FDA on the state of industry and emerging trends of the Advanced Therapy Medicinal Products (ATMP) and current status of Serialization Track & Trace
• Exploration of cutting-edge modalities such as gene therapies & novel delivery system
• Case studies Thailand’s first hospital-based GMP-IND for ATMP
• Getting the global overview of Serialization Track & Trace, the evolution journey and update technologies
• Learning key success factors for transferring APIs, finished dosage forms, and analytical methods between sending and receiving sites, CMOs, and R&D facilities
• Exploring the complexity of maintaining QMS & how to embed Quality Culture
• Learning about Formality in Quality Risk Management (QRM aligned with ICHQ9)
• Exploring the integrating of QRM and C&Q, aligning with the latest ASTM E2500 updates
• Learning on contamination control, efficiency & regulatory expectation in Material Transfer
• Experiencing case studies on upgrading existing cleanrooms to meet the revised Annex 1
• Learning how Pharma Facilities can integrate eco-design, renewable energy, and smart automation to achieve long-term sustainability goals
• Learning how to reduce energy consumption and carbon footprint with innovative Technology such as membrane-based WFI generation, Magnetic Bearing Chiller, EC Fans in HVAC systems & Heat Pumps
• Exploring how to embrace Pharma 4.0, AI, & data-driven quality systems to accelerate innovation and compliance
• Learning from the global pharmaceutical company, Takeda Pharmaceutical Japan, their journey in building a unified manufacturing data platform across sites

GMP, Quality, Sustainability

Online Registration Browse website www.ispeth.org/agm2026. ****For pharmacists who attend this course will receive 11.50 accredits.****